Suppr超能文献

抗生素策略对手术治疗的坏死性小肠结肠炎结局的影响。

The Impact of Antibiotic Strategy on Outcomes in Surgically Managed Necrotizing Enterocolitis.

机构信息

Texas Tech Health Sciences Center El Paso, Paul L. Foster School of Medicine, El Paso, TX, USA.

Rady Children's Hospital, San Diego and University of California San Diego School of Medicine, San Diego, CA, USA.

出版信息

J Pediatr Surg. 2024 Jul;59(7):1266-1270. doi: 10.1016/j.jpedsurg.2024.03.019. Epub 2024 Mar 14.

Abstract

BACKGROUND

We sought to evaluate postoperative antibiotic practices in a large population of patients with necrotizing enterocolitis (NEC) and determine whether any regimens were associated with better outcomes.

METHODS

The Pediatric Health Information Systems (PHIS) database was queried to identify patients who underwent an intestinal resection for acute NEC between July, 2016 and June, 2021. Data regarding post-resection antibiotic therapy, cutaneous or intraabdominal infection, and fungal or antibiotic-resistant infection were collected.

RESULTS

130 infants at 38 children's hospitals met inclusion criteria. Postoperative antibiotics were administered for a median of 13 days. The most frequently used antibiotics were vancomycin and piperacillin/tazobactam. Antibiotic duration greater than five days was not associated with a lower incidence of infection. No antibiotic was associated with a lower incidence of any of the complications assessed, although ampicillin was associated with more infections, overall. The incidence of fungal infection and treatment with a parenteral anti-fungal medication was greater with vancomycin. No antibiotic combination was used enough to be assessed.

CONCLUSIONS

Administration of antibiotics for more than five days after resection for NEC was not associated with better infectious outcomes and no single antibiotic demonstrated superior efficacy. Consistent with prior studies, fungal infections were more frequent with vancomycin.

TYPE OF STUDY

Retrospective database study, level 3B.

LEVEL OF EVIDENCE

II.

摘要

背景

我们旨在评估大量坏死性小肠结肠炎(NEC)患者的术后抗生素治疗方案,并确定任何方案是否与更好的结果相关。

方法

使用儿科健康信息系统(PHIS)数据库检索 2016 年 7 月至 2021 年 6 月间接受急性 NEC 肠切除术的患者。收集术后抗生素治疗、皮肤或腹腔感染以及真菌感染或抗生素耐药感染的数据。

结果

在 38 家儿童医院的 130 名婴儿符合纳入标准。术后抗生素治疗的中位时间为 13 天。最常使用的抗生素是万古霉素和哌拉西林/他唑巴坦。抗生素使用时间超过五天与感染发生率降低无关。没有哪种抗生素与评估的任何并发症的发生率降低相关,尽管氨苄西林总体上与更多感染相关。真菌感染的发生率和使用静脉用抗真菌药物治疗的情况,万古霉素更高。没有足够的抗生素组合可以评估。

结论

NEC 切除术后使用抗生素超过五天与更好的感染结果无关,也没有哪种抗生素显示出更好的疗效。与既往研究一致,万古霉素更易引起真菌感染。

研究类型

回顾性数据库研究,等级 3B。

证据等级

II。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验